Africa Cancer Leaders Institute

非洲癌症领袖研究所

基本信息

批准号：
10754192
负责人：
OLUFUNMILAYO F. OLOPADE
金额：
$ 3万
依托单位：
UNIVERSITY OF CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-09-20 至 2026-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10754192
关键词：
Advocacy Africa African Area Award Clinical Clinical Trials Collaborations Competence Country Development Early identification Education Electronic Medical Records and Genomics Network Emerging Technologies Ethics Evaluation Faculty Fostering Foundations Friends Funding Future Generations Genetic Genomics Goals Grant Income Individual Knowledge Leadership Learning Location Malignant Neoplasms Mentors Mentorship Minority Participant Pathology Persons Policies Portuguese Productivity Publications Publishing Records Regional Cancer Reporting Research Research Personnel Research Training Role Senegal Training Translating Travel United States National Institutes of Health Woman aluminum sulfate anticancer research brain circulation cancer therapy career career development clinical development cohort design experience forging improved innovation leadership development lectures meetings member novel strategies outreach peer peer coaching programs recruit research and development symposium

项目摘要

PROJECT SUMMARY The proposed renewal application for African Cancer Leaders Institute (ACLI) is a “meeting within a meeting” designed to coincide with conferences organized by the African Organization for Research Training In Cancer (AORTIC) conference, beginning with the forthcoming, “Cancer in Africa: Implementation, Workforce, and Opportunities” in Dakar, Senegal, November 3-8, 2023.The ACLI will identify early career researchers, especially women and individuals underrepresented in global cancer research who are capable of leading interdisciplinary teams to improve cancer treatment in Africa. The long-term goal of the ACLI is to provide an intellectually stimulating platform to propel emerging global cancer leaders from Africa and the US to receive support for innovative cancer research in Africa, and to stimulate an African network for emerging leaders in cancer research. The ACLI platform will have annual goals and objectives set by the Education and Research Sub- Committees of AORTIC in collaboration with the ACLI program Organizers. The ACLI will widely solicit competitive applications from aspiring leaders in Africa and the US. During the past funding cycle, three cohorts of ACLI participants (60 total) were recruited and participated in AORTIC Conferences in Durban in 2017, Maputo in 2019 and Senegal in 2022 during a mini-retreat for ACLI members and AORTIC Council Members at the 1st African Regional Cancer Conference (ARCC) planned and hosted by AORTIC Leadership in West Africa. Awardees from all cohorts were invited to participate and 21 attended in person. It was gratifying to note enthusiastic participation by investigators from West Africa, especially those from French and Portuguese speaking countries. Most of the ARCC lectures were given by ACLI participants and researchers working in Africa who reported having received 6 NIH and 5 foundation grants. ACLI participants were unanimous in endorsing the need for a regional conference every other year that will provide greater capacity building opportunities and more succinct leadership programing for ACLI. For this renewal application, 10 Emerging Leaders will be fully-funded for travel to attend the AORTIC conference and participate in ACLI activities. Five emerging Leaders from high-income countries with meritorious abstracts and application will be selected for Merit travel award in order to continue to forge professional relationships and foster peer mentorship. ACLI participants will mostly network in groups of 6-8 with conversations on specific topics facilitated by Faculty and attend scientific sessions. For peer mentoring, sessions will be arranged for ACLI participants to discuss and evaluate concepts presented at the conference to enhance learning and career development experience. Each new ACLI participant will be asked to prepare a brief 15-minute overview of career accomplishments and plans for their career development activities. We will continue to track a number of metrics including conference evaluations, career landmarks, publication records and the number of ACLI members who compete successfully for Africa focused NIH/NCI grants e.g K43, K07, K23, R21 etc.

项目概要非洲癌症领袖研究所 (ACLI) 拟议的续展申请是一次“会议中的会议” 旨在与非洲癌症研究培训组织组织的会议同时举行（AORTIC）会议，首先是即将举行的“非洲癌症：实施、劳动力和机会”，塞内加尔达喀尔，2023 年 11 月 3 日至 8 日。ACLI 将甄选早期职业研究人员，特别是在全球癌症研究中代表性不足、有能力领导跨学科的女性和个人 ACLI 的长期目标是提供智力支持。刺激平台，推动来自非洲和美国的新兴全球癌症领导者获得支持非洲的创新癌症研究，并刺激非洲癌症领域新兴领导者网络 ACLI 平台将制定由教育和研究小组制定的年度目标。 AORTIC 委员会与 ACLI 计划组织者合作，ACLI 将广泛征求意见。在过去的资助周期中，来自非洲和美国有抱负的领导人的竞争性申请。的 ACLI 参与者（总共 60 名）被招募并参加了 2017 年在德班、马普托举行的 AORTIC 会议 2019 年和 2022 年塞内加尔在 ACLI 成员和 AORTIC 理事会成员于 1 日举行的小型务虚会上非洲区域癌症会议 (ARCC) 由西非 AORTIC Leadership 策划和主办。令人欣慰的是，所有组别的获奖者均受邀参加，并有 21 人亲自出席。西非特别是法国和葡萄牙调查人员的热情参与大多数 ARCC 讲座都是由 ACLI 参与者和在这些国家工作的研究人员进行的。非洲报告获得了 6 名 NIH 和 5 名 ACLI 参与者的一致同意。赞同需要每隔一年举行一次区域会议，以加强能力建设对于 ACLI 的机会和更简洁的领导力规划，10 新兴项目。领导人将获得全额资助前往参加 AORTIC 会议和参加 ACLI 活动。来自高收入国家的五位具有杰出摘要和应用的新兴领导人将入选优秀旅行奖，以继续建立专业关系并培养同行 ACLI 参与者大多以 6-8 人为一组进行交流，就特定主题进行对话。由教师协助并参加科学会议对于同行指导，将为 ACLI 安排会议。与会者讨论和评估会议上提出的概念，以促进学习和职业发展每个新的 ACLI 参与者将被要求准备一份 15 分钟的简短概述。我们将继续跟踪他们的职业成就和职业发展活动计划。指标包括会议评估、职业里程碑、发表记录和 ACLI 数量成功竞争以非洲为重点的 NIH/NCI 拨款的成员，例如 K43、K07、K23、R21 等。